John M. Hill Jr. MD

Contact Information:

Phone: (603) 650-4628

Fax: (603) 650-2334

Email: not given

Institution Affiliations:

Director, Allogeneic Blood and Marrow Transplant Program

Assistant Professor of Medicine

Department of: MEDICINE

Section: Hematology/Oncology

Specialty: Hematology

Joined Staff: 2002

Cancer Center Membership:

Blood and Marrow Transplant Program

Lymphoma / Leukemia Clinical Oncology Group

Clinical Interests:

Board Certified:

Hematology 2000

Medical Oncology 1999

Internal Medicine 1995

Degree(s): MD

University of Connecticut School of Medicine, Farmington, CT 1989

Internship(s):

National Naval Medical Center, Bethesda, MD, (Internal Medicine) 1989-90

Naval Undersea Medical Institute, Groton, CT, (Diving/Undersea Medicine) 1990-91

Residency:

National Naval Medical Center, Bethesda, MD, (Internal Medicine) 1993-95

Fellowship(s):

National Naval Medical Center, Bethesda, MD, (Hematology/Oncology) 1995-98

Fred Hutchinson Cancer Research Center, Seattle, WA, (Bone Marrow Transplant) 1997-98

Georgetown University Medical Center, Washington, DC, (Bone Marrow Transplant) 1998-98

Biography:

Dr. Hill received his BA in 1982 from Princeton University and his MD in 1989 from the University of Connecticut School of Medicine. Dr. Hill completed his internship and residency in 1995 from the National Naval Medical Center and his Hematology/Oncology Fellowship in 1998 from the NCI. In 1998 Dr. Hill joined the faculties of Uniformed Services University of Health Sciences in Bethesda, MD and the National Naval Medical Center. In July 2002 Dr. Hill joined the Section of Hematology/Oncology of the DHMC as hematologist in the Hematology/BMT Program.

Research Interests:

Clinical trial development.

Leukemia/Lymphoma Clinical Trials

Multiple Myeloma Clinical Trials

Myelodysplastic Clinical Trials

Selected Publications:

Hill JM, Webber S, Fitzmaurice TF, Cole BF, Szczepiorkowski Z, Meehan KR. Factors Underlying Early Lymphocyte Recovery and Associated Survival Benefit Following Autologous Stem Cell Transplant for Lymphoproliferative Disorders. Biol. of Blood and Marrow Transplant. 2004 (publication pending)

Hill JM, Patchett LJ, Webber S, Langweiler M, Wu J, Szczepiorkowski Z, Meehan KR. Use of Peripheral Blood CD34 Analysis as a Marker for Leukapheresis Suitability: Marked Reduction in Resource Utilization and Cost During Stem Cell Collection. Biol. of Blood and Marrow Transplant. 2004 (publication pending)

Mailing Address:
Norris Cotton Cancer Center
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756